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Abstract. Vascular leakage is an important feature of various disease conditions. In vivo optical imaging
provides a great opportunity for the evaluation of this phenomenon. In the present study, we focus on the devel-
opment and validation of a near-infrared (NIR) imaging formula to allow reliable, cost-efficient evaluation of vas-
cular leakage in diverse species using the existing small-animal fluorescence imaging technology. IR-676, a
moderately hydrophobic NIR cyanine dye, was doped into self-assembling aqueous micelles using a widely
employed and safe nonionic emulsifier (Kolliphor HS 15), and was tested in several acute and chronic inflam-
matory disease models in both mice and rats. The imaging formula is stable and exerts no acute toxic effects
in vitro. It accumulated specifically in the inflamed regions in all models, which could be demonstrated by both
conventional epifluorescence imaging, and fluorescence tomography both as a standalone technique and
also by merging it with computed tomography scans. Ex vivo verification of dye accumulation by confocal
fluorescence microscopy was also possible. The present formula allows sensitive and specific detection of
inflammatory plasma leakage in diverse models. Its potential for imaging larger animals was also demonstrated.
IR-676-doped micelles offer an excellent opportunity to image inflammatory vascular leakage in various models
and species. © The Authors. Published by SPIE under a Creative Commons Attribution 3.0 Unported License. Distribution or reproduction of this
work in whole or in part requires full attribution of the original publication, including its DOI. [DOI: 10.1117/1.JBO.20.1.016022]
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1 Introduction
The interest in near-infrared (NIR) optical in vivo imaging is
constantly growing since its debut in the early 2000s,1 and
the sensitivity and versatility of the instruments have increased
considerably since then. However, there is only a narrow range
of reliable contrast agents currently available, and this is espe-
cially true for fluorescence markers dedicated to image plasma
leakage from diseased vasculature. Most of these probes either
suffer from low contrast and signal-to-background ratio, or have
tremendous operational costs, thereby limiting large-scale imag-
ing, and in general, do not enable studies involving research
animals larger than mice.
The dilation and increased permeability of the microvessels
caused by the contraction of the endothelial cells in the area of
inflammation and subsequent formation of intercellular gaps is
an important adaptive change during acute vascular hyper-
permeability, as this helps the transmigration of immune cells
(e.g., leukocytes, T, and B cells) as well as the transport of anti-
bodies and inflammatory mediators to the site of the disease.2
Prolonged tissue ischemia and the following reperfusion
leads to a similarly increased perfusion and permeability of
the vasculature within the affected area. This process leads to
the formation of a plasma protein-rich fluid exudate as well,
thereby contributing to edema formation, a characteristic feature
of acute inflammation. This takes place primarily in the postca-
pillary venules.3 Chronic vascular hyperpermeability (CVH) is
mainly observed in tumors and chronic inflammatory conditions
such as rheumatoid arthritis or immune-mediated dermatitis.
The main difference of CVH is that the plasma leakage occurs
primarily from newly formed pathological, “leaky” vessels with
weakened endothelial structures.3
It is not surprising that noninvasive, longitudinal, real-time
evaluation of these processes provides a great opportunity to
estimate the extent and characteristics of these conditions, for
which NIR optical imaging is an excellent alternative in preclini-
cal settings compared to other modalities (computed tomogra-
phy etc.) due to the availability of tabletop instruments and
lack of ionizing radiation.4
The underlying principle of optical in vivo imaging of this
phenomenon is based on employing NIR fluorophores (emis-
sion maximum between 650 and 900 nm), whose particle size
is great enough to limit their escaping from healthy vasculature
under normal conditions; however, they retain their ability to*Address all correspondence to: Balint Botz, E-mail: balint.botz@gmail.com
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leave leaky vessels of inflamed or tumor tissues. The earliest
example was the Evans-blue method (Miles-assay), which relied
on the iv. administration of the azo dye with high affinity for
serum albumin, for which the degree of extravasation could be
traditionally determined by spectrophotometry.3 It was recently
demonstrated though that ex vivo NIR imaging of the affected
organs is superior in terms of both specificity and sensitivity,5
and in vivo fluorescence imaging of this dye is also feasible.6
Unfortunately, this technique gives meaningful results only with
a very high amount of concentrated dye, which necessitates the
sacrificing of the subject, and can be easily biased if the residual
dye in the vasculature is not properly removed. Consequently
several authors employed other, mainly cyanine fluorophores
such as indocyanine green (ICG), Cy5.5, or IR-820 which
also have nonspecific binding ability to albumin and other
plasma proteins.7–10 The signal strength and contrast of these
techniques remained relatively modest despite the high doses
administered, presumably due to aspecific binding, small size,
and the short plasma half-life (typically only minutes) of these
compounds regardless of plasma protein binding (as the paren-
chymal cells of the liver rapidly clear these substances from the
circulation). However, these studies substantiated that (1) cya-
nine dyes are, in general safe, and can be used for noninvasive
tracking of plasma extravasation and (2) the signal intensity of
extravasated dye is relatively stable, mainly due to nonspecific
uptake by phagocytes. Among the dyes currently used, ICG
received by far the most attention despite its significant disad-
vantages compared to novel, advanced cyanine fluorophores
(low stability in aqeous media and low quantum yield, small
Stokes-shift, autoaggregation, as well as poor solubility in
physiologic buffers) as it is currently the only FDA-approved
NIR-dye due to historical reasons.11 Additionally, its cytotoxic
effects have also been reported.12,13 An advanced ICG-derivative
SIDAG demonstrated somewhat better sensitivity and lower
toxicity than ICG; nevertheless, it still required relatively large
doses to be administered and contrast remained negligible at
early imaging time points.14
To overcome the difficulties outlined above, and to get better
results, several investigators prepared preformulated NIR con-
trast agents that do not rely on plasma protein binding either
by (1) performing a controlled labeling of a macromolecule
(albumin, dextranes, etc.) in vitro, prior to use15–18 or (2) syn-
thesizing fluorescently labeled microparticles whose extravasat-
ing capabilities are limited by their size.19–21 The latter method
could especially provide additional benefits, as the incorporation
of the dye into a nanoprobe minimizes the potential cytotoxicity
and delays systemic elimination, thereby leading to prolonged
plasma half-life. Here, we have employed Kolliphor HS 15 for
this purpose, a nonionic solubilizer that forms stable micelles in
water and physiologic buffers with an average size of 12 nm,
and has a negligible toxicity on its own.22
Based on these findings there is a particular need in preclini-
cal inflammation and vascular research to have an NIR contrast
agent with the following characteristics: (1) absolute compati-
bility with both the existing fluorescence molecular tomo-
graphic technology and confocal fluorescence microscopy to
enable ex vivo verification, (2) imaging capability of both super-
ficial and deep-tissue plasma leakage with a broad spectrum of
applicability, (3) simple and cost-efficient synthesis requiring
only standard life sciences laboratory equipment, and down-
to-earth steps during the process, and (4) potential for imaging
larger animals (rats etc.). Therefore, we aimed at synthesizing
a novel formula to fulfill these criteria and validate it in well
established and routinely used rodent inflammation models of
different organs.
2 Materials and Methods
2.1 Preparation of the IR-676-Doped Micelles
The moderately hydrophobic pentamethine cyanine fluorescent
dye IR-676 (1,1′,3,3,3′,3′-hexamethyl-4,5,4′,5′-dibenzoindodi-
carbocyanine)-iodide [Fig. 1(a)] was selected as a promising
candidate, as (1) it has low water solubility (but is still not
insoluble), and is moderately soluble in other polar solvents
(e.g., lower alcohols) (2) its excitation/emission wavelength
maxima differ only marginally from some other widely used
“gold standard” NIR fluorophores (Cy5.5, Alexa Fluor 680,
etc.), thereby ensuring compatibility with the existing imaging
technology and wavelength filters. It has also been previously
demonstrated that this dye is an excellent calibration standard
for fluorescence tomography systems.23 IR-676 was obtained
in powder form (MW: 610.58 g∕mol, excitation maximum:
676 nm, emission maximum: 700 nm, Spectrum-Info Ltd.,
Kyiv, Ukraine). The dye can be easily dissolved in dichlorome-
thane or alcohols.23,24 Taking into consideration the incompat-
ibility of dichloromethane with most plastic materials, the dye
was initially dissolved in methanol at room temperature (RT),
and was ultrasonicated then stirred until it formed a clear,
deep blue solution with a concentration of 2 × 10−4 M. This sta-
ble stock solution was either immediately used, or stored at
−20°C protected from light. 100 μl batches were pipetted
into microtubes which were covered with a parafilm membrane
pierced by a 27G needle three to four times to allow evaporation
of the solvent at a moderate rate. The vials were then centrifuged
for at least 60 min in a Speed Vac centrifuge (Savant RVT4104
refrigerated vapor trap, Savant Instruments Inc, Farmingdale,
New York), leaving behind a thin film of dried dye at the bottom
of the vial, which was stored light protected at 4°C. For the
reconstitution, a 5 w/v% solution of the nonionic surfactant
Kolliphor HS 15 (Polyethylene glycol-15-hydroxystearate,
Sigma-Aldrich) was prepared in sterile deionised water.
Kolliphor HS 15 was selected based on its outstanding in vivo
safety and previously demonstrated effectiveness for imaging
contrast agent formulas such as ICG.22,25–26 500 μl batches of
this medium were directly pipetted into the microtubes contain-
ing the dye at RT. Complete dissolution of IR-676 could be
achieved within 10 to 20 min by vortexing and ultrasonication.
The resulting stable solution (4 × 10−5 M) was either immedi-
ately used, or stored at 4°C for a maximum of 48 h.
2.2 Animals
For the experiments, 10 to 12-week-old C57Bl/6 mice (weigh-
ing 20 to 25 g) and 5-week-old Wistar rats (weighing 125–
150 g) were used, for which the original breeding pairs were
obtained from Charles-River Hungary Ltd. (Budapest, Hungary).
The animals were bred in the Laboratory Animal House of
the Department of Pharmacology and Pharmacotherapy at the
University of Pécs, fed with standard rodent chow and water
ad libitum, kept at 24°C to 25°C ambient temperature and
12-h light-dark cycles. The studies were approved by the Ethics
Committee on Animal Research of the University of Pécs
according to the Ethical Codex of Animal Experiments (license
No: BA 02/2000-2/2012 and BA02/2000-5/2011).
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2.3 Imaging Protocol
The IR-676-based contrast agent was injected iv. in a dosage of
2 × 10−7 mol∕kg body weight, corresponding to a convenient
injectate volume of 100 to 150 μl for mice or 0.6 to 0.8 ml
for rats. The method of delivery was either lateral tail vein
(oxazolone- and carrageenan-model) or retro-orbital injection
(in the other models). Imaging was performed at several selected
time-points with the in vivo imaging system (IVIS) Lumina II
(PerkinElmer Ltd., Waltham, Massachusetts) with a 640-nm
excitation (535, 570, and 605 for spectral unmixing) and
∼700-nm emission filters, auto exposure time, and a binning fac-
tor of 2. Fluorescencewas expressed as the total radiant efficiency
[ðphotons∕s∕cm2∕steradianÞ∕ðμW∕cm2Þ]. The fluorescence
molecular tomography (FMT) 2000 system (PerkinElmer Ltd.)
was calibrated using the instrument’s 680-nm laser channel, and
a sample solution of 1 × 10−6 M following the instructions of
the instrument’s manufacturer. Imaging with the FMT system
was performed uniformly 3 h postinjection due to the lower
throughput of the three-dimensional (3-D) imaging system
using high-resolution acquisition parameters. Fluorescence
was expressed as either the calculated amount of fluorophore
(pmol) or as surface fluorescence (counts/energy). In the airway
inflammation model, the extent of the inflamed area was also
expressed in μm3. Animals were anesthetized for the injection
and imaging with ketamine-xylazine ip. (dosage: 100∶5 mg∕kg).
During anesthesia, body temperature was maintained by a heating
lamp and vital signs were monitored by observation until recovery.
Home cage activity after recovery was also observed.
2.4 Interaction with Serum Proteins
To determine whether IR-676 binds to serum proteins in its
freely dissolved or encapsulated state, ethanol-based (20 v/v
%) or micellar (5 w/v%) solutions (10 μl, 4 × 10−5 M) of
the dye were incubated with bovine serum albumin (BSA)
(0.5 mg∕ml), fetal bovine serum (FBS), and horse serum
(HS) (10x dilution) samples (100 μl) at RT. Additionally, the
encapsulated dye was also incubated in an equal amount of
deionised water. 10 μl batches of the samples were mixed
with an equal amount of loading dye (bromophenol-blue solu-
tion) and 10 μl of the mixtures were pipetted into the gel. To
preserve the physiologic protein structure and potential nonspe-
cific binding, samples were separated by nondenaturing polya-
crylamide gel electrophoresis (PAGE) (100 V, 1.5 h, Tris/glycine
buffer).27 Gels were scanned using the IVIS Lumina II, then
stained with Coomassie brilliant blue and imaged again using
the same settings (Note: the fluorescence spectra of the two
dyes overlap, and the methanol-based Coomassie-staining pro-
cedure removes IR-676 from the gel).
2.5 In Vitro Toxicity Screening
The biological safety of the formula was evaluated on the
Chinese Hamster Ovary (CHO-K1) cell line. Cells were trypsi-
nized, washed, and resuspended in PBS at a density of
2 × 105∕ml. 50 or 100 μl batches of the imaging formula or
the vehicle alone were added to 1 ml amounts of cells; thereafter,
the cells were incubated for 5 min at 37°C, pelleted by centrifu-
gation at 1000 rpm for 5 min, after which they were resuspended
in 1 ml PBS. Cell viability was evaluated by the fluorescein
diacetate-propidium iodide (FDA/PI) assay,28 as 500 μl batches
of each sample were stained with either FDA (1 μl of an 500-
mM stock solution in dry DMSO) or PI (5 μl of 0.75-mM stock
solution) and incubated for 10 min. Viable cells fluoresce in
green as they enyzmatically convert FDA to fluorescin, whereas
dead cells fluoresce in red as PI stains the nuclei after passing
through the damaged cell membranes. 2 × 104 cells∕cohort were
evaluated by a CyFlow flow cytometer (Partec Ltd., Münster,
Fig. 1 The structure of IR-676 and the binding ability of the formula
to serum proteins. (a) IR-676 displays a pentamethine cyanine back-
bone structure similarly to other, more common fluorophores (Cy5.5
etc.). As the side chains are single methyl groups, the water-solubility
and reactivity of the dye is low. (b) IR-676 fluorescence measurement
following native polyacrylamide gel electrophoresis of bovine serum
albumin (BSA), fetal bovine serum (FBS), and horse serum (HS) sam-
ples incubated with ethanol (20 v/v%) or Kolliphor HS 15 (5 w/v%)-
based solutions of IR-676. (c) Fluorescence image of the same gel
following protein-staining with Coomassie brilliant blue.
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Germany). Untreated and 6% formalin fixed cells were used to
set the gates for living and dead cells, respectively. The percent-
ages of viable and nonviable cells were calculated by identical
gating for each sample.
2.6 Preparation of the Frozen Ear Sections for
Microscopy
The samples were embedded in a frozen section compound
(FSC 22, Surgipath Ltd., Richmond, Illinois), immediately fro-
zen in liquid nitrogen, and stored at −80°C. The samples were
cryosectioned (8 μm), and imaged within 24 h by an Olympus
FluoView 1000 confocal laser scanning fluorescence micro-
scope (Olympus, Center Valley, Pennsylvania). Single optical
sections were taken from areas of interest using a 40× objective.
2.7 Oxazolone-Induced Contact Dermatitis
Mouse Model
The ear model of oxazolone-induced allergic contact dermatitis
was previously validated as a robust, reliable disease model,
leading to localized edema and sensitization, as well as inflam-
matory cell activation primarily mediated by Th1 cell
response.29 Moreover, it has been recently demonstrated as a
good proof-of-concept model to test potential NIR tracers of
vascular leakage.30 Anesthetized mice were sensitized on two
consecutive days by applying 50 μl 2% oxazolone (Sigma-
Aldrich) onto the shaved abdomen. Six days later, 15 − 15 μl
of 2% oxazolone was applied on both the inner and outer sur-
faces of the right ear, whereas the left ear was treated with the
vehicle only (96% ethanol) to serve as control. The oxazolone
treatment induces a marked hyperemia and edema within
hours, accompanied by leukocyte influx and T cell infiltration.
Subjects were injected with the contrast agent 24 h later, and
were repeatedly imaged between 5 to 180 min postinjection
with the IVIS Lumina II. Thereafter, the mice were sacrificed,
and ears were collected for cryosection histology.
2.8 Lipopolysaccharide-Induced Acute Airway
Inflammation Mouse Model
The LPS model is a reliable tool to investigate acute inflamma-
tory changes of the airways and lungs, and has been validated
and optimized by our workgroup before.31 In the present series
of experiments, a modified, direct intratracheal delivery was
used, since our preliminary experiments demonstrated that
the conventionally used intranasal route produces far too high
intra-group variations for in vivo imaging, Mice were anes-
thetized, and a PE-10 cannula was carefully introduced into
the trachea via the mouth by a novel technique allowing simple
visualization of the vocal cords.32 The airway inflammation was
induced by intratracheal instillation of 60 μl PBS in which
100 μg dry, purified Escherichia coli (serotype: 083) endotoxin
was dissolved while controls received PBS. 21 h after LPS treat-
ment, the mice were injected with the contrast agent, and they
were imaged 3 h later by the FMT 2000 imaging system.
2.9 K/BxN Serum-Transfer Arthritis Mouse Model
The K/BxN serum-transfer model is a reliable immune-medi-
ated model of rheumatoid arthritis, which is based on the trans-
fer of autoantibody-rich sera from the spontaneously arthritic
K/BxN mice into healthy recipients, thus eliciting a transient
polyarthritis. Sera were obtained from the K/BxN mice, pooled,
and stored at −80°C as described earlier.33 To induce a systemic
polyarthritis, mice were injected ip. with 300 μl serum diluted to
1 ml with sterile PBS. Subjects were injected 7 days after
arthritis induction, and were imaged 3 h postinjection using
the FMT 2000 system.
2.10 Carrageenan-Induced Acute Paw Inflammation
Model of the Rat
This model was selected to evaluate the feasibility of in vivo
imaging of larger species with this contrast agent. Carrageenan
is a complex polysaccharide which elicits a massive edema for-
mation, local hyperemia, and consequent leukocyte accumula-
tion, thus serving as a reliable model of acute inflammation.34
Wistar rats under anesthesia received an intraplantar injection of
100 μl 1% carrageenan (Sigma-Aldrich) in the left hindpaw,
while the right paw was injected with an equal volume of saline.
Two hours later, the animals were injected with the contrast
agent, and were imaged 60 and 120 min postinjection with
the IVIS Lumina II.
2.11 Statistical Analysis
Results are expressed as mean±standard error of the mean.
Statistical evaluation was performed by Graphpad Prism®.
The imaging results in the oxazolone model were evaluated
by two-way ANOVA with Sidak’s multiple comparisons test,
while other imaging results were achieved by Student’s two-
tailed t-test. At least p < 0.05 was considered significant.
3 Results
3.1 The IR-676-Based Formula Demonstrates
Negligible Binding to Serum Proteins
The nondenaturing-PAGE demonstrated that IR-676 binds
weakly if at all to serum proteins regardless of being present
as freely dissolved (ethanol) or encapsulated (Kolliphor HS
15). As strong fluorescence was exclusively observed in the
wells where micellar IR-676-containing samples were pipetted,
which did not propagate in the gel, we can conclude that the
formula did not disintegrate even when exposed to strong elec-
tric current, and its size prevented it from entering into the gel
[Figs. 1(b) and 1(c)].
3.2 The Dye Formula Has No Impact on Cell
Viability in the Fluorescein Diacetate-Propidium
Iodide Acute Toxicity Assay
Exposing CHO-K1-cells to two concentrations of the formula or
the vehicle alone exerted no apparent acute toxic effects. The
percentage of viable and dead cells showed minimal fluctuations
between study groups (Table 1). As the higher concentration
employed (100 μl formula∕1 ml cell suspension) exceeded
even the expected peak plasma concentration upon intravenous
injection, we assume that the present formula poses minimal
if any risks of toxicity within its suggested operational range.
Although no formal in vivo toxicity tests were performed, we
carefully observed IR-676-treated animals to assess any major
untoward effect. No lethality occurred throughout the study and
no observable pathological sign was ever found upon close
inspection of the animals during and after anesthesia. Heart
rate, as well as respiratory frequency and depth remained regu-
lar, and no changes in skin color and visible mucous membranes
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were seen. Dye-injected animals regained consciousness nor-
mally and afterward showed normal home cage activity (loco-
motion, eating/drinking, climbing, and grooming). Based on
these observations and the in vitro cytotoxicity data, we can con-
clude that the potential in vivo acute toxicity of the dye is of
minor significance.
3.3 IR-676-Doped Micelles Selectively Accumulate
in Areas Affected by Chemically Induced
Contact Dermatitis in Mouse Ear
Immediately 10 min postinjection, the contrast agent yielded a
more than 260% greater signal in the inflamed ears than on the
contralateral noninflamed side. Moreover, the signal strength
showed minimal variations in the vehicle-treated ears, demon-
strating the importance of body weight-based dosage. In the fol-
lowing 3 h, the signal strength slowly decreased in the control
ears indicating the gradual clearance of the dye-loaded micelles
from the circulation. At 3 h, the fluorescence intensity in the
affected ears was more than 650% higher than in the controls,
pointing out the prolonged presence of the extravasated dye
molecules in diseased tissues [Figs. 2(a) and (b)]. The confocal
fluorescence microscopic examination supported these findings,
showing a patchy accumulation of the fluorophore in the peri-
vascular regions within oxazolone-treated ears [Fig. 2(c)].
3.4 Imaging of Deep-Tissue Inflammation of
the Mouse Airways
The 3-D tomographic imaging of the LPS-treated mice 3 h post-
injection demonstrated considerably greater signal strength in
the areas corresponding to the airways. Whereas in the thoracic
area of PBS-treated control mice, the calculated amount of
Table 1 Fluorescein diacetate/propidium iodide (FDA/PI) toxicity assay
results. Chinese Hamster Ovary (CHO-K1) cells (1 ml of a 2 × 105 cells∕
ml suspension) were incubated in the presence of the dye formula or the
vehicle alone, and were subsequently stained with FDA (stains viable
cells) or PI (stains dead cells) to assess their viability. 2 × 104 cells were
evaluated by flow cytometry to represent each experimental condition.
Propidium iodide
Fluorescein
diacetate
Live (%) Dead (%) Live (%) Dead (%)
Control culture 96.85 3.15 95.63 4.37
Vehicle (50 μl) 95.98 4.02 94.55 5.45
Vehicle (100 μl) 97.44 2.56 97.08 2.92
Dye formula (50 μl) 97.72 2.28 95.42 4.58
Dye formula (100 μl) 96.9 3.1 94.18 5.82
Fig. 2 Oxazolone-induced acute dermatitis on the mouse ear. (a) Representative in vivo epifluorescence
images taken 10 and 180 min following intravenous injection of the formula. (b) The changes of fluores-
cence intensity in the 96% ethanol-treated control and oxazolone-treated inflamed ears throughout the
measurement (n ¼ 7, ****p < 0.0001). (c) Representative confocal fluorescence microscopy images of
the control and inflamed ears harvested 3 h postinjection clearly demonstrating the tissue localization of
the dye (Note: the autofluorescence of the ear cartilage is shown to provide visual aid).
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IR-676 was only 15 to 20 pmol, LPS-treated mice displayed
a 120 to 130 pmol signal strength in the respective regions
[Figs. 3(a) and 3(c)]. Additionally, the area of increased plasma
extravasation was significantly greater in LPS-treated mice
than in the controls (on average 700 versus 200 μm3) demon-
strating that a diffuse region was affected by the LPS-induced
pulmonary inflammation [Figs. 3(b) and 4]. IR-676 showed
a strong accumulation in the liver, similarly to other cyanine
dyes. This, however, could be easily demarcated from the spe-
cific signal (despite being at least a magnitude greater) in the
3-D tomographic scans. In contrast, it was not possible to sep-
arate the specific signal from the liver signal in the 2-D epifluor-
escence scans [Fig. 3(d)] due to the scattering of the latter.
3.5 Visualization of Immune-Mediated Polyarthritis
of the Mouse Ankle Joints
In the control mice, the fluorescence in the hindlimbs was
negligible 3 h after the injection (less than 1 pmol or not quan-
tifiable) and was not localized in the ankle joints. In comparison,
the K/BxN serum-treated mice displayed a circumscribed,
Fig. 3 Endotoxin-induced acute airway inflammation of the mouse. (a) The measured total amount of
fluorophore (pmol) in the thoracic region 24 h following LPS- or PBS-challenge, 3 h after the injection of
the probe. (b) The tissue volume (μm3) affected by increased dye-accumulation. (c) Representative
three-dimensional (3-D) fluorescence tomographic reconstructions. (d) Conventional epifluorescence
images of the same mice for comparison. (n ¼ 6∕group, **p < 0.01, ***p < 0.001).
Fig. 4 Microcomputer tomography-fluorescence tomography co-
registration of an LPS-treated mouse. The animal was immediately
transferred upon completion of the FMT-scan into the micro-CT
(Skyscan 1176, Bruker, Kontich, Belgium) remaining within the imag-
ing cassette, where a CT-imaging of the respective region was per-
formed. The scans were individually reconstructed, and were merged
together using the AMIDE software based on three-dimensional
fiducial markers present on the imaging cassette. (Video 1, MPEG,
0.92 MB) [URL: http://dx.doi.org/10.1117/1.JBO.20.1.016022.1].
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increased signal accumulation (∼12 pmol on average)
corresponding to the region of the tibiotarsal joints (affected
principally by the disease), in sharp contrast to their controls
[Figs. 5(a) to 5(c) and 6]. Conventional 2-D-scans of the
same set of mice yielded similar results [Figs. 5(b) to 5(d)].
3.6 Imaging Acute Carrageenan-Induced Paw
Edema in the Rat
The accumulation of signal in the treated hindpaws of the rats
was clearly visible both 1 and 2 h postinjection, the signal
strength being 50% and 80% greater than in the sham-treated
control paws. The observed lower contrast is potentially caused
by the circumscribed, local inflammation around the site of
carrageenan-injection which leaves most of the paw unaffected.
Thus, only a small part of the paw becomes actually inflamed,
causing a comparatively modest signal surplus over the non-
specific ambient background [Figs. 7(a) and 7(b)].
4 Discussion
The primary outcome of our study is that we successfully com-
pounded a novel IR-676 dye-containing NIR imaging formula
for both in and ex vivo imaging. It can be rapidly and economi-
cally established and easily mass produced for routine experi-
mental applications using only the standard equipment and
common reagents of a life sciences laboratory, with the sole
exception of the fluorophore. We have validated the adaptability
of our contrast agent in a range of different inflammation models
in distinct organs displaying different characteristics regarding
the underlying pathophysiological changes, and it proved to be
a highly sensitive and perfectly reproducible tool to detect vas-
cular leakage in mouse ear, joint and lung, as well as the rat paw.
Fig. 5 K/BxN serum-induced chronic polyarthritis of the mouse. (a) The total amount of fluorophore in the
ankle joints of intact and K/BxN serum-treated mice, 7 days after disease induction and 3 h following the
probe injection. (b) Fluorescence intensity calculated on the basis of the conventional epifluorescence
scans in the same joints. (c) Representative three-dimensional representations and (d) epifluorescence
images of the same mice (Note: the numbering of the tail by a permanent marker created artifacts on
the 2-D-scans). (n ¼ 6 − 7∕group, ****p < 0.0001:).
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The observed superior contrast and signal-to-noise ratio can be
attributed to several different factors: (1) employing a hydropho-
bic dye ensures complete encapsulation of the fluorophore and
makes the amount of free dye in the aqueous phase negligible.
This results in easier preparation (since it is not neccessary to
test the encapsulation-efficiency); moreover, it reduces the
unspecific signal from healthy tissues, which is produced at
least partially by the free dye. (2) Rigorous observance of
body weight-based dosage. According to our results, this
alone can greatly enhance specificity mainly by reducing the
variation of signal strength in controls (as observed, e.g., in
the oxazolone-experiment). However, fluctuation within the dis-
eased groups will nevertheless be present due to the intrinsic
biological variations of the models.
Fluorophores encapsulated into self-assembling, micropar-
ticles using biologically inert surfactants represent a simple,
yet sensitive method to evaluate a wide variety of inflammatory
diseases and to follow tumor progression in vivo. A similar
concept has recently been described for two-photon imaging
microscopy using a di-stryl benzene derivative.35 Kolliphor
HS 15 and other nontoxic nonionic surfactants (Pluronic,
Cremophor etc.) have been validated for the encapsulation of
ICG within self-assembling micelles and provide a good solu-
tion to countervent the rapid clearance of the dye.25,36
Nevertheless, some intrinsic problems of ICG still remain: its
low quantum yield (necessitating at least a magnitude higher
doses), its tendency to autoaggregate, and its broad excitation
and emission maxima, making specific filtering of its fluores-
cence difficult. Additionally, its good water solubility poses
the risk of high unspecific signal due to the unpredictable
kinetics and biodistribution of the free dye. IR-676, in contrast,
has a quantum yield comparable to most other advanced fluo-
rophores (lower amounts are needed for sensitive detection),24
and has definitive peak excitation and emission maxima, which
match the parameters of the current NIR lasers and filters, as
these are almost identical to the respective parameters of the
most widely used NIR dyes (Cy5.5, Alexa Fluor 680 etc.).
Moreover, the poor water solubility of IR-676 minimizes the
presence of freely dissolved dye in the solution. We observed
that IR-676 displays a robust liver accumulation, therefore, im-
aging disease conditions within the liver or in its close proximity
are not technically possible with the present formula. We have to
emphasize, however, that this is a common feature of all the
other cyanine fluorophores, as well.4,19 Additionally, it is impor-
tant to note that the emission maximum of this dye lies very
close to that of chlorophyll (680 to 740 nm) which is abundantly
present in most standard rodent food pellets. Therefore, for im-
aging in the abdominal region mice should be previously fed
with alfalfa-free food to reduce abdominal autofluorescence.37
Traditionally, good water solubility was deemed as one of
the essential pharmacological characteristics of fluorophores
employed in in vivo imaging.11 While this is generally beneficial
for fluorophores intended to be used for labeling, moderate
hydrophobicity increases the efficiency of micellar encapsula-
tion and reduces unspecific background fluorescence. However,
it is also important to keep in mind that lipophilic substances can
have an unspecific cytotoxic effect by influencing the plasma
membrane fluidity.38 However, our in vitro toxicity screening
test suggests that the present formula is relatively inert within its
operational range, as we observed no toxic effects on CHO-K1
cells. As IR-676 is (1) not entirely hydrophobic, (2) as it was
coated by the surfactant, and (3) as the employed dosage was
very low compared to other similar studies, its possible in vivo
effect (if present) was marginal at best, and caused no
observable behavioral or physiologic alterations in the animals
similarly to other closely related cyanine dyes.13
As a conclusion, the novel in vivo imaging formula presented
here provides excellent sensitivity and high specificity in a wide
range of disease models, both in superficial and deep-tissues,
and it can be more easily and economically prepared using
Fig. 7 Carrageenan-induced acute paw inflammation in the rat. (a) Fluorescence intensity in the saline
and carrageenan-treated hindpaw (IV injection performed 2 h after disease induction), measured by epi-
fluorescence imaging 60 and 120 min postinjection. (b) Representative images of the vehicle (right) and
carrageenan-treated (left) hindlimbs (Note: the tail was covered to prevent possible interference caused
by the concentrated dye present on the site of the IV injection). (n ¼ 4, **p < 0.01)
Fig. 6 Micro-CT-fluorescence tomography coregistration of an arthritic
mouse. (Video 2, MPEG, 0.92 MB) [URL: http://dx.doi.org/10.1117/1
.JBO.20.1.016022.2].
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standard laboratory equipment without any complicated steps in
the process as compared to the existing state-of-the-art NIR
plasma extravasation contrast agents. Additionally, this formula
can be seamlessly incorporated into most optical imaging instru-
ments, even the fluorescent optical tomography system. IR-676-
doped micelles present an excellent opportunity for the non-
invasive optical imaging of plasma extravasation, and also
make in vivo imaging of these disease conditions in larger
species realistically feasible (as demonstrated on rats) due to
the easy and economical large-scale synthesis of the formula.
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